Home » Topics » Regulatory » Patents

Patents
RSS

Novel protease inhibitors in development at Enanta for the treatment of HCV infections

Nov. 23, 2009

Merck & Co. describes CGRP receptor antagonists for the treatment of migraine

Nov. 23, 2009

AstraZeneca claims chemokine CX3CR1 receptor antagonists

Nov. 20, 2009

Novel antimitotic agents claimed by Korean scientists for the treatment of cancer

Nov. 20, 2009

BMS claims four series of novel NS5B inhibitors for treatment of HCV infection

Nov. 20, 2009

Insulin secretion stimulators described by Merck KGaA for the treatment of hyperglycemia

Nov. 20, 2009

Vertex is developing ABC transporter modulators for the treatment of cystic fibrosis

Nov. 19, 2009

5-HT, DA and NE reuptake inhibitors disclosed by GSK for the treatment of anxiety

Nov. 19, 2009

Novel histamine receptor modulators in early development at Medivation

Nov. 19, 2009

Schering-Plough claims A2A receptor antagonists for the treatment of PD

Nov. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...